European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality?
Straznicky
Nora
N
Human Neurotransmitters/Neurovascular Hypertension and Kidney Disease Laboratories, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Grassi
Guido
G
Esler
Murray
M
Lambert
Gavin
G
Dixon
John
J
Lambert
Elisabeth
E
Jordan
Jens
J
Schlaich
Markus
M
D000328:Adult; D019440:Anti-Obesity Agents / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D004039:Diet, Sodium-Restricted; D015444:Exercise; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009765:Obesity / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D040242:Risk Reduction Behavior; D015431:Weight Loss
D019440:Anti-Obesity Agents; D000959:Antihypertensive Agents